[1]
S. LINGABATHULA and N. JAIN, “STABILITY INDICATIVE AND COST EFFECTIVE ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF FAVIPIRAVIR AND PERAMIVIR IN BULK AND PHARMACEUTICAL DOSAGE FORM BY USING RP-HPLC”, Int J App Pharm, vol. 13, no. 4, pp. 265–271, Jul. 2021.